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OBJECTIVES We assessed the short- and long-term clinical and angiographic outcome of nonocclusive
unstented dissection after percutaneous transluminal coronary angioplasty (PTCA) and its
correlation with restenosis.
BACKGROUND The use of stents has dramatically increased both the number and the cost of coronary
revascularization procedures. However, this technique is not completely risk free, and its
benefits have not been fully demonstrated in uncomplicated dissections.
METHODS We studied 129 consecutive patients with 49 nonocclusive dissections after PTCA (grades A
to D of National Heart, Lung, and Blood Institute classification) and good distal flow (TIMI
[Thrombolysis in Myocardial Infarction] flow grade 3). All patients underwent coronary
angiography at 24 h and at six months post-PTCA. Clinical status was assessed every three
months in the outpatient clinic. Study subjects were matched with 60 other patients in whom
stenting was performed for the presence of dissection.
RESULTS In the former group, all but two patients (with type E dissection, which evolved to coronary
occlusion and myocardial infarction) improved their dissection score during follow-up: at six
months only 18 dissections were still angiographically visible, and no clinical adverse events
were recorded. In the dissected vessels, the restenosis rate was significantly lower than in those
without dissection (12% vs. 44%, p , 0.001); in the stented vessels, the restenosis rate was
25% (15/60).
CONCLUSIONS In the presence of TIMI flow grade 3, coronary dissection is associated with a favorable
outcome and predicts a low restenosis rate. These results caution against the indiscriminate
use of intravascular prostheses in the event of nonocclusive coronary dissection. (J Am Coll
Cardiol 1999;34:1484–8) © 1999 by the American College of Cardiology
The use of endovascular prostheses (stents) has dramatically
influenced the growth of nonsurgical myocardial revascular-
ization procedures. Indeed, the extensive application of
See page 1489
stents yielded the extension of these procedures to a broader
spectrum of clinical and anatomical situations, and allowed
the accomplishment of better short- (1) and long-term (2,3)
results. However, stenting has also produced an increase in
procedural costs, and it is associated with a rate of restenosis
that is not always as favorable as reported in major random-
ized trials (2,3). This is especially true when stenting is
employed to repair a dissection, as the technique is not
completely devoid of risks and complications (4–6). Among
the various procedural events prompting stent application,
coronary dissection remains the most frequent one. Indeed,
regardless of angiographic definitions (7) or morphological
classification (8), the incidence of coronary dissection after
percutaneous transluminal coronary angioplasty (PTCA)
ranges from 9% to 45% (9,10). Furthermore, autoptic
(11–15) and intravascular imaging studies (16,17) show the
presence of dissection after percutaneous coronary interven-
tions in 50% to 80% of patients.
Dissection grade is known to contribute to the immediate
result of PTCA (6,8,18,19); therefore, stent insertion,
besides allowing better management of this complication,
has also determined a reduction in the incidence of abrupt
occlusions. The more friendly use of stents without the need
of systemic anticoagulation has increased the disposition of
most operators to implant a stent following almost any
dissection occurring after PTCA (20). Although this ap-
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proach may contribute to the safety of the procedure by
decreasing the occurrence of abrupt vessel closure, the
frequent need of long or multiple stents to cover a dissection
fully may not necessarily lead to a low restenosis rate.
Therefore, it appears appropriate to evaluate the natural
history of coronary dissection occurring after angioplasty,
for a better definition of its natural evolution may lead to a
more selective use of stents.
We report here our experience, gathered in a relatively
large patient population, treated conservatively despite the
angiographic evidence of a dissection-complicating PTCA.
We review the short- and long-term effects of this compli-
cation, and we try to interpret our observations in the
context of the available literature.
METHODS
Patients. We investigated the results obtained in 129
consecutive patients (103 men; mean age 53 6 11 years)
with stable angina, who were treated with only balloon
angioplasty (PTCA). This cohort was recruited in the initial
phase of our experience in interventional cardiology, when
the use of coronary stenting was not readily available in our
institution.
We also assessed a second group of 60 consecutive
patients, clinically and angiographically matched with the
previous group, predominantly (90%) with one-vessel dis-
ease, who came to our observation at a later stage of our
interventional experience and underwent single-vessel
PTCA and stent implantation for the presence of a dissec-
tion after PTCA (TIMI [Thrombolysis in Myocardial
Infarction] flow grade 3 in all patients).
Angioplasty. All patients undergoing coronary angioplasty
were pretreated with aspirin, and a heparin intravenous (IV)
bolus of 10,000 U was administered at the beginning of the
procedure. In all patients the percent stenosis (and resten-
osis defined as a stenosis .50% at follow-up angiography)
was determined by quantitative coronary angiography
(QCA); both electrocardiogram (ECG) and blood pressure
were monitored continuously throughout the procedure and
for 30 min thereafter. During this time, additional coronary
injections were performed every 5 to 10 min after PTCA
completion to verify vessel patency and contrast runoff.
Total creatine kinase (CK) (normal ,200 IU/liter) and
creatine kinase–myocardial band (CK-MB) isoenzyme
(normal ,10%) were measured immediately after procedure
and every 4 h for 12 h, and finally at 24 h post-PTCA.
Nonocclusive dissection. Nonocclusive dissection was
noted by each operator and then reviewed by a second
investigator. It was defined as an angiographically visible
intraluminal filling defect, extraluminal opacity, or flap
complicating the dilation site, unassociated with symptoms
and/or ischemic ECG alterations, or with impaired distal
filling, at the end of the procedure. The severity of the
dissection was scored on the basis of the National Heart,
Lung, and Blood Institute (NHLBI) classification (8), and
defined as follows: type A, radiolucent area within the
lumen with minimal or no persistence of contrast; type B,
parallel double lumen separated by a radiolucent area with
minimal or no persistence of contrast; type C, persistent
presence of contrast outside the coronary lumen; type D,
spiral luminal filling defect; type E, dissection with persis-
tent filling defect; type F, dissection with total coronary
occlusion.
In the “stented” group, the prostheses were implanted to
cover completely the dissection utilizing high pressures for
deployment. The decision to implant the stent in these
patients was based on the operator’s choice (elective, fol-
lowing Institute guidelines). In all, a ticlopidine (250 mg
b.i.d.) and aspirin (100 mg once daily [od]) combination
was used after stenting for one month. Patients were then
treated indefinitely with aspirin alone and other cardiac
medications as required.
All patients of both groups underwent repeat coronary
angiography 24 h and six months after PTCA; furthermore,
they all attended regular visits to our outpatient clinic for a
six-month follow-up.
Statistical analysis. All data were expressed as the mean
value 6 SD. The chi-square test was performed to analyze
the association of restenosis with categoric variables (SPSS
statistical software package, Cary, North Carolina). A p
value , 0.05 was accepted as statistically significant.
RESULTS
The clinical and angiographic features of study patients are
shown in Table 1. In the group of patients only undergoing
balloon angioplasty (129 patients, 111 with single-vessel
disease and 18 with two-vessel disease), 147 coronary
stenoses were treated. At the end of the procedure an
angiographically visible dissection was present in 51 sites
(35%). Of these, two type E dissections, in patients with
two-vessel disease, evolved toward complete artery occlusion
during the procedure and caused an acute myocardial
infarction, and therefore they were excluded from the final
analysis. The remaining 49 dissections (45 patients, of
whom 4 had two-vessel disease) were not associated with
either symptoms, ECG or enzymatic signs of myocardial
ischemia, and did not impair distal flow, which remained
Abbreviations and Acronyms
CK-MB 5 creatine kinase–myocardial band
ECG 5 electrocardiogram, electrocardiographic
NHLBI 5 National Heart, Lung, and Blood Institute
PTCA 5 percutaneous transluminal coronary
angioplasty
QCA 5 quantitative coronary angiography
TIMI 5 Thrombolysis in Myocardial Infarction
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TIMI grade 3 throughout the procedure. Prolonged infla-
tions with a perfusion balloon were not performed in any
case. As expected, the highest rate of dissections occurred in
B and C lesions. No clinical or angiographic differences
were present between patients with and without dissection.
Figure 1 shows the distribution of dissections in the
different severity classes and their evolution at 24 h and at
six months. At 24 h, coronary dissection was still visible in
41 (all in patients with single-vessel disease) of the 49 initial
sites; worsening was noted in 2 lesions (4%, from grades B
to C), whereas improvement was observed in 12 (24%). At
six months, 25 other lesions (61%) had improved: 23
dissections had disappeared and only 18 (12%) were still
angiographically visible.
Figure 2 illustrates an example of the angiographic
evolution of type B dissection at 24 h and at six months.
Of the remaining 145 lesions treated, 51 (35%) showed
restenosis at six months. Among these, 5 (5/41, 12%)
occurred in dissected lesions (all in patients with single-
vessel disease), whereas 46 (46/106, 44%) occurred in vessels
with no dissection (in particular, 37 patients with single-
vessel disease and 9 single lesions in patients with bivessel
disease) (x2 5 13.2, p 5 0.0002). When the analysis was
performed using the patients instead of the lesions, 5/41
Figure 1. Evolution of the dissections during the first 24 h and at
six-month follow-up. A, B, C, D 5 degree of dissection (see text
for explanation).
Table 1. Baseline Clinical and Angiographic Characteristics of Patients
PTCA Group
STENT
Group
Mean age 6 SD (yrs) 55 6 11 50 6 8 57 6 10
No. of male patients (%) 103 (80) 40 (89) 51 (85)
Recent MI (,3 months), no. (%) 14 (11) 4 (9) 7 (11)
Single-vessel disease, no. (%) 111 (86) 41 (91) 54 (90)
Vessel dilated no.
LAD 66 (45) 20 (41) 30 (50)
LCX 49 (33) 6 (12) 11 (18)
RCA 32 (22) 23 (47) 19 (32)
No. type A, B, C lesions 29-81-37 8-12-29 10-35-15
Type A, B, C lesions (%) 20-55-25 16-24-60 17-58-25
No. type A-B-C-D dissections 33-10-4-2 0-34-19-7
Mean diameter stenosis pre-PTCA (%) 85 6 11 87 6 8 79 6 19
Mean reference artery diameter pre-PTCA (mm) 3.20 6 0.54 3.18 6 0.7 3.30 6 0.61
Mean diameter stenosis post-PTCA (%) 20 6 7 8 6 8
Mean diameter stenosis post-PTCA 24 h (%) 24 6 5 10 6 9
Mean diameter stenosis post-PTCA 6 months (%) R 75 6 9 71 6 14
(% nR) 20 6 10 10 6 8
Mean lumen diameter post-PTCA (mm) 3.23 6 0.65 3.41 6 0.55
Mean lumen diameter post-PTCA 24 h (mm) 3.09 6 0.54 3.37 6 0.48
Mean lumen diameter post-PTCA 6 months (mm R) 0.78 6 0.51 0.85 6 0.48
(mm nR) 3.01 6 0.47 3.24 6 0.61
Mean diameter stenosis post-PTCA dissected vessels (%) 22 6 18
Mean diameter stenosis post-PTCA 24 h dissected vessels (%) 23 6 16
Mean diameter stenosis post-PTCA 6-month dissected vessels (% R) 80 6 8
(% nR) 24 6 9
Mean lumen diameter post-PTCA dissected vessels (mm) 3.11 6 0.89
Mean lumen diameter post-PTCA 24 h dissected vessels (mm) 3.09 6 0.16
Mean lumen diameter post-PTCA 6-month dissected vessels (mm R) 0.88 6 0.42
(mm nR) 3.02 6 0.64
MI 5 myocardial infarction; LAD 5 left anterior descending; LCX 5 left circumflex; RCA 5 right coronary artery; R 5 restenosis; nR 5 nonrestenosis. Data referring to
patients with dissection after PTCA are in bold.
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patients with dissection versus 46/88 without dissection
showed restenosis (x2 5 18.8, p , 0.0001).
During follow-up, 85 of the 129 patients remained
angina-free, whereas 44 (34%) developed recurrent symp-
toms (4/5 in patients with dissection and 40/46 in patients
without dissection): of these, 40 had restenosis. No other
cardiac events occurred during the six-month follow-up.
In patients treated with stent (a single 15-mm stent in
55/60 lesions), the dissection grade was, respectively, 56%,
32% and 12% for grades B, C and D. Unstented patients
had a higher prevalence of A and B dissection grades (85%
vs. 56%) as compared to stented patients. However, no
difference among stented and unstented patients was found
when they were categorized according to dissection type.
The rates of restenosis and recurrent angina were 25%
(15/60) and 20%, respectively. Albeit lower, these figures
were not significantly different from those observed in
“unstented” patients. No other relevant clinical events were
observed in this cohort.
DISCUSSION
The results of our study indicate that discrete dissections are
associated with a very low incidence of acute and long-term
complications and do not increase the incidence of resten-
osis. Indeed, in the dissected vessels, the restenosis rate was
12%, a significantly lower figure than that observed in those
without dissection (44%) and in the “stented group” (25%).
Although the exiguity of the figures examined does not
allow us to draw conclusions on the “protective” role of
dissection against restenosis, our observation agrees with
previous studies (21–23).
Our results suggest that the use of stents is not mandatory
to manage dissection, although a different approach has to
be used when this complication is associated with an
unsatisfactory angiographic result, either because of signif-
icant residual stenosis or a filling defect, which suggests the
presence of overlying thrombus or an intimal flap. The
fundamental condition that warrants a conservative ap-
proach when facing this type of complication is represented
by the clinical stability of the patient, namely the absence of
symptoms, ECG and hemodynamic modifications along
with the persistence of a TIMI grade 3 flow. Whenever all
these conditions are met, the short- and long-term progno-
sis seems to be more than satisfactory.
Comparison with previous studies. The results of our
study are in agreement with previous data by Huber et al. (8)
and Sharma et al. (18), who showed that “minor” dissections
are associated with a lower risk of ischemic complications
than are “major” ones. Hermans et al. (21) as well as Cripps
et al. (24) demonstrated that even more extensive dissec-
tions had a good long-term follow-up when patients have
no ischemic manifestations at the end of the procedure.
Clinical implications. How can we manage the “good, bad
and ugly coronary balloon angioplasty dissection”? (7). And
when does the use of a stent become warranted? Probably,
in all those cases, when the relation among dissection
severity, vessel size, procedural difficulties and concomitant
anatomic characteristics is largely favorable. In other words,
a type A–B dissection, involving the middle or distal portion
of a relatively tortuous vessel with #2.5 mm diameter, is
probably to be treated conservatively. Conversely, a type D
Figure 2. (A) Eccentric stenosis of the proximal segment of the
left anterior descending coronary artery; (B) PTCA final result: a
type B dissection is observed at the site of dilation. After 24 h this
result was unchanged; (C) angiography six-months after the
procedure.
1487JACC Vol. 34, No. 5, 1999 Cappelletti et al.
November 1, 1999:1484–8 Unstented Nonocclusive Coronary Dissection After PTCA
dissection involving the proximal portion of a $3 mm
diameter artery will require stent application, especially
when the result is suboptimal and/or an intimal flap is
evident.
Conclusions. Our results show that nonocclusive coronary
dissection is a frequent and relatively benign complication of
PTCA that is not associated with increased incidence of
restenosis. Moreover, both its short- and long-term clinical
evolution and angiographic evolution are generally predict-
able, and the persistence of TIMI grade 3 flow, along with
the absence of ischemia, generally permits us to exclude the
occurrence of sudden coronary occlusion. We recognize that
our study was conducted in a relatively limited patient
cohort. However, all patients were carefully followed and all
underwent angiography at 24 h and at six months post-
PTCA. We believe that the lack of significant clinical and
angiographic differences associated with stented and un-
stented dissections suggests that the use of endovascular
prostheses should be carefully evaluated in patients without
flow-limiting coronary artery dissection.
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